[
  {
    "ts": null,
    "headline": "OPKO Health Bets on RAYALDEE and Pipeline Progress for 2026 Growth",
    "summary": "OPK leans on RAYALDEE momentum and strategic partnerships as pipeline trials advance, though reliance on its lone U.S. drug adds risk.",
    "url": "https://finnhub.io/api/news?id=e375b88f5bc129cb0d1e35f36c362e72f156e9aa6dffb400feef678bda5d98dd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767701100,
      "headline": "OPKO Health Bets on RAYALDEE and Pipeline Progress for 2026 Growth",
      "id": 138000191,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "OPK leans on RAYALDEE momentum and strategic partnerships as pipeline trials advance, though reliance on its lone U.S. drug adds risk.",
      "url": "https://finnhub.io/api/news?id=e375b88f5bc129cb0d1e35f36c362e72f156e9aa6dffb400feef678bda5d98dd"
    }
  }
]